Gastric motility drugs, also known as prokinetic drugs, are drugs that promote the forward movement of gastrointestinal contents. When gastric motility is low, the emptying of gastric contents is delayed, which can cause many gastrointestinal diseases, such as nausea, vomiting, heartburn, postprandial discomfort, dyspepsia, etc., and can cause gastroesophageal reflux, leading to esophageal ulcer. Gastric motility drugs are used clinically to treat related diseases, such as reflux symptoms, reflux esophagitis, dyspepsia, intestinal obstruction and other common diseases.

The global Gastric Motility Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Gastric Motility Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastric Motility Drugs.

Report Scope

The Gastric Motility Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gastric Motility Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Gastric Motility Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Gastric Motility Drugs Market Report

Report Metric	Details
Report Name	Gastric Motility Drugs Market
CAGR	5%
Segment by Type	Monotherapy Poly Pill
Segment by Application	Chronic Gastritis Reflux Esophagitis Functional Dyspepsia Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Johnson & Johnson, Sumitomo Dainippon, Sanofi, Pfizer, Teva, GrupoFarma, Abbott, Kyowa Kirin, Sigma-Tau Group, Wilmington, Chengdu Kanghong Pharmaceutical Group Co.,Ltd, Lunan Pharmaceutical Group Corporation, Hansoh Pharmaceutical Group Company Limited, Shanghai Sine Pharmaceutical Laboratories Co., Ltd, Disha Pharmaceutical Group Co., Ltd, Xian Janssen Pharmaceutical Ltd
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Gastric Motility Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Gastric Motility Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Gastric Motility Drugs Market report?

Ans: The main players in the Gastric Motility Drugs Market are Johnson & Johnson, Sumitomo Dainippon, Sanofi, Pfizer, Teva, GrupoFarma, Abbott, Kyowa Kirin, Sigma-Tau Group, Wilmington, Chengdu Kanghong Pharmaceutical Group Co.,Ltd, Lunan Pharmaceutical Group Corporation, Hansoh Pharmaceutical Group Company Limited, Shanghai Sine Pharmaceutical Laboratories Co., Ltd, Disha Pharmaceutical Group Co., Ltd, Xian Janssen Pharmaceutical Ltd

What are the Application segmentation covered in the Gastric Motility Drugs Market report?

Ans: The Applications covered in the Gastric Motility Drugs Market report are Chronic Gastritis, Reflux Esophagitis, Functional Dyspepsia, Others

What are the Type segmentation covered in the Gastric Motility Drugs Market report?

Ans: The Types covered in the Gastric Motility Drugs Market report are Monotherapy, Poly Pill

1 Gastric Motility Drugs Market Overview

1.1 Product Overview and Scope of Gastric Motility Drugs

1.2 Gastric Motility Drugs Segment by Type

1.2.1 Global Gastric Motility Drugs Market Value Comparison by Type (2024-2030)

1.2.2 Monotherapy

1.2.3 Poly Pill

1.3 Gastric Motility Drugs Segment by Application

1.3.1 Global Gastric Motility Drugs Market Value by Application: (2024-2030)

1.3.2 Chronic Gastritis

1.3.3 Reflux Esophagitis

1.3.4 Functional Dyspepsia

1.3.5 Others

1.4 Global Gastric Motility Drugs Market Size Estimates and Forecasts

1.4.1 Global Gastric Motility Drugs Revenue 2019-2030

1.4.2 Global Gastric Motility Drugs Sales 2019-2030

1.4.3 Global Gastric Motility Drugs Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Gastric Motility Drugs Market Competition by Manufacturers

2.1 Global Gastric Motility Drugs Sales Market Share by Manufacturers (2019-2024)

2.2 Global Gastric Motility Drugs Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Gastric Motility Drugs Average Price by Manufacturers (2019-2024)

2.4 Global Gastric Motility Drugs Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Gastric Motility Drugs, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Gastric Motility Drugs, Product Type & Application

2.7 Gastric Motility Drugs Market Competitive Situation and Trends

2.7.1 Gastric Motility Drugs Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Gastric Motility Drugs Players Market Share by Revenue

2.7.3 Global Gastric Motility Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Gastric Motility Drugs Retrospective Market Scenario by Region

3.1 Global Gastric Motility Drugs Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Gastric Motility Drugs Global Gastric Motility Drugs Sales by Region: 2019-2030

3.2.1 Global Gastric Motility Drugs Sales by Region: 2019-2024

3.2.2 Global Gastric Motility Drugs Sales by Region: 2025-2030

3.3 Global Gastric Motility Drugs Global Gastric Motility Drugs Revenue by Region: 2019-2030

3.3.1 Global Gastric Motility Drugs Revenue by Region: 2019-2024

3.3.2 Global Gastric Motility Drugs Revenue by Region: 2025-2030

3.4 North America Gastric Motility Drugs Market Facts & Figures by Country

3.4.1 North America Gastric Motility Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Gastric Motility Drugs Sales by Country (2019-2030)

3.4.3 North America Gastric Motility Drugs Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Gastric Motility Drugs Market Facts & Figures by Country

3.5.1 Europe Gastric Motility Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Gastric Motility Drugs Sales by Country (2019-2030)

3.5.3 Europe Gastric Motility Drugs Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Gastric Motility Drugs Market Facts & Figures by Country

3.6.1 Asia Pacific Gastric Motility Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Gastric Motility Drugs Sales by Country (2019-2030)

3.6.3 Asia Pacific Gastric Motility Drugs Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Gastric Motility Drugs Market Facts & Figures by Country

3.7.1 Latin America Gastric Motility Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Gastric Motility Drugs Sales by Country (2019-2030)

3.7.3 Latin America Gastric Motility Drugs Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Gastric Motility Drugs Market Facts & Figures by Country

3.8.1 Middle East and Africa Gastric Motility Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Gastric Motility Drugs Sales by Country (2019-2030)

3.8.3 Middle East and Africa Gastric Motility Drugs Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Gastric Motility Drugs Sales by Type (2019-2030)

4.1.1 Global Gastric Motility Drugs Sales by Type (2019-2024)

4.1.2 Global Gastric Motility Drugs Sales by Type (2025-2030)

4.1.3 Global Gastric Motility Drugs Sales Market Share by Type (2019-2030)

4.2 Global Gastric Motility Drugs Revenue by Type (2019-2030)

4.2.1 Global Gastric Motility Drugs Revenue by Type (2019-2024)

4.2.2 Global Gastric Motility Drugs Revenue by Type (2025-2030)

4.2.3 Global Gastric Motility Drugs Revenue Market Share by Type (2019-2030)

4.3 Global Gastric Motility Drugs Price by Type (2019-2030)

5 Segment by Application

5.1 Global Gastric Motility Drugs Sales by Application (2019-2030)

5.1.1 Global Gastric Motility Drugs Sales by Application (2019-2024)

5.1.2 Global Gastric Motility Drugs Sales by Application (2025-2030)

5.1.3 Global Gastric Motility Drugs Sales Market Share by Application (2019-2030)

5.2 Global Gastric Motility Drugs Revenue by Application (2019-2030)

5.2.1 Global Gastric Motility Drugs Revenue by Application (2019-2024)

5.2.2 Global Gastric Motility Drugs Revenue by Application (2025-2030)

5.2.3 Global Gastric Motility Drugs Revenue Market Share by Application (2019-2030)

5.3 Global Gastric Motility Drugs Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Johnson & Johnson

6.1.1 Johnson & Johnson Corporation Information

6.1.2 Johnson & Johnson Description and Business Overview

6.1.3 Johnson & Johnson Gastric Motility Drugs Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Johnson & Johnson Gastric Motility Drugs Product Portfolio

6.1.5 Johnson & Johnson Recent Developments/Updates

6.2 Sumitomo Dainippon

6.2.1 Sumitomo Dainippon Corporation Information

6.2.2 Sumitomo Dainippon Description and Business Overview

6.2.3 Sumitomo Dainippon Gastric Motility Drugs Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Sumitomo Dainippon Gastric Motility Drugs Product Portfolio

6.2.5 Sumitomo Dainippon Recent Developments/Updates

6.3 Sanofi

6.3.1 Sanofi Corporation Information

6.3.2 Sanofi Description and Business Overview

6.3.3 Sanofi Gastric Motility Drugs Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Sanofi Gastric Motility Drugs Product Portfolio

6.3.5 Sanofi Recent Developments/Updates

6.4 Pfizer

6.4.1 Pfizer Corporation Information

6.4.2 Pfizer Description and Business Overview

6.4.3 Pfizer Gastric Motility Drugs Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Pfizer Gastric Motility Drugs Product Portfolio

6.4.5 Pfizer Recent Developments/Updates

6.5 Teva

6.5.1 Teva Corporation Information

6.5.2 Teva Description and Business Overview

6.5.3 Teva Gastric Motility Drugs Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Teva Gastric Motility Drugs Product Portfolio

6.5.5 Teva Recent Developments/Updates

6.6 GrupoFarma

6.6.1 GrupoFarma Corporation Information

6.6.2 GrupoFarma Description and Business Overview

6.6.3 GrupoFarma Gastric Motility Drugs Sales, Revenue and Gross Margin (2019-2024)

6.6.4 GrupoFarma Gastric Motility Drugs Product Portfolio

6.6.5 GrupoFarma Recent Developments/Updates

6.7 Abbott

6.6.1 Abbott Corporation Information

6.6.2 Abbott Description and Business Overview

6.6.3 Abbott Gastric Motility Drugs Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Abbott Gastric Motility Drugs Product Portfolio

6.7.5 Abbott Recent Developments/Updates

6.8 Kyowa Kirin

6.8.1 Kyowa Kirin Corporation Information

6.8.2 Kyowa Kirin Description and Business Overview

6.8.3 Kyowa Kirin Gastric Motility Drugs Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Kyowa Kirin Gastric Motility Drugs Product Portfolio

6.8.5 Kyowa Kirin Recent Developments/Updates

6.9 Sigma-Tau Group

6.9.1 Sigma-Tau Group Corporation Information

6.9.2 Sigma-Tau Group Description and Business Overview

6.9.3 Sigma-Tau Group Gastric Motility Drugs Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Sigma-Tau Group Gastric Motility Drugs Product Portfolio

6.9.5 Sigma-Tau Group Recent Developments/Updates

6.10 Wilmington

6.10.1 Wilmington Corporation Information

6.10.2 Wilmington Description and Business Overview

6.10.3 Wilmington Gastric Motility Drugs Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Wilmington Gastric Motility Drugs Product Portfolio

6.10.5 Wilmington Recent Developments/Updates

6.11 Chengdu Kanghong Pharmaceutical Group Co.,Ltd

6.11.1 Chengdu Kanghong Pharmaceutical Group Co.,Ltd Corporation Information

6.11.2 Chengdu Kanghong Pharmaceutical Group Co.,Ltd Gastric Motility Drugs Description and Business Overview

6.11.3 Chengdu Kanghong Pharmaceutical Group Co.,Ltd Gastric Motility Drugs Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Chengdu Kanghong Pharmaceutical Group Co.,Ltd Gastric Motility Drugs Product Portfolio

6.11.5 Chengdu Kanghong Pharmaceutical Group Co.,Ltd Recent Developments/Updates

6.12 Lunan Pharmaceutical Group Corporation

6.12.1 Lunan Pharmaceutical Group Corporation Corporation Information

6.12.2 Lunan Pharmaceutical Group Corporation Gastric Motility Drugs Description and Business Overview

6.12.3 Lunan Pharmaceutical Group Corporation Gastric Motility Drugs Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Lunan Pharmaceutical Group Corporation Gastric Motility Drugs Product Portfolio

6.12.5 Lunan Pharmaceutical Group Corporation Recent Developments/Updates

6.13 Hansoh Pharmaceutical Group Company Limited

6.13.1 Hansoh Pharmaceutical Group Company Limited Corporation Information

6.13.2 Hansoh Pharmaceutical Group Company Limited Gastric Motility Drugs Description and Business Overview

6.13.3 Hansoh Pharmaceutical Group Company Limited Gastric Motility Drugs Sales, Revenue and Gross Margin (2019-2024)

6.13.4 Hansoh Pharmaceutical Group Company Limited Gastric Motility Drugs Product Portfolio

6.13.5 Hansoh Pharmaceutical Group Company Limited Recent Developments/Updates

6.14 Shanghai Sine Pharmaceutical Laboratories Co., Ltd

6.14.1 Shanghai Sine Pharmaceutical Laboratories Co., Ltd Corporation Information

6.14.2 Shanghai Sine Pharmaceutical Laboratories Co., Ltd Gastric Motility Drugs Description and Business Overview

6.14.3 Shanghai Sine Pharmaceutical Laboratories Co., Ltd Gastric Motility Drugs Sales, Revenue and Gross Margin (2019-2024)

6.14.4 Shanghai Sine Pharmaceutical Laboratories Co., Ltd Gastric Motility Drugs Product Portfolio

6.14.5 Shanghai Sine Pharmaceutical Laboratories Co., Ltd Recent Developments/Updates

6.15 Disha Pharmaceutical Group Co., Ltd

6.15.1 Disha Pharmaceutical Group Co., Ltd Corporation Information

6.15.2 Disha Pharmaceutical Group Co., Ltd Gastric Motility Drugs Description and Business Overview

6.15.3 Disha Pharmaceutical Group Co., Ltd Gastric Motility Drugs Sales, Revenue and Gross Margin (2019-2024)

6.15.4 Disha Pharmaceutical Group Co., Ltd Gastric Motility Drugs Product Portfolio

6.15.5 Disha Pharmaceutical Group Co., Ltd Recent Developments/Updates

6.16 Xian Janssen Pharmaceutical Ltd

6.16.1 Xian Janssen Pharmaceutical Ltd Corporation Information

6.16.2 Xian Janssen Pharmaceutical Ltd Gastric Motility Drugs Description and Business Overview

6.16.3 Xian Janssen Pharmaceutical Ltd Gastric Motility Drugs Sales, Revenue and Gross Margin (2019-2024)

6.16.4 Xian Janssen Pharmaceutical Ltd Gastric Motility Drugs Product Portfolio

6.16.5 Xian Janssen Pharmaceutical Ltd Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Gastric Motility Drugs Industry Chain Analysis

7.2 Gastric Motility Drugs Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Gastric Motility Drugs Production Mode & Process

7.4 Gastric Motility Drugs Sales and Marketing

7.4.1 Gastric Motility Drugs Sales Channels

7.4.2 Gastric Motility Drugs Distributors

7.5 Gastric Motility Drugs Customers

8 Gastric Motility Drugs Market Dynamics

8.1 Gastric Motility Drugs Industry Trends

8.2 Gastric Motility Drugs Market Drivers

8.3 Gastric Motility Drugs Market Challenges

8.4 Gastric Motility Drugs Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Lunan Pharmaceutical Group Corporation

Shanghai Sine Pharmaceutical Laboratories Co., Ltd.

Xian Janssen Pharmaceutical Ltd.

GrupoFarma

Chengdu Kanghong Pharmaceutical Group Co.,Ltd

Hansoh Pharmaceutical Group Company Limited

Disha Pharmaceutical Group Co., Ltd

List of Tables

Table 1. Global Gastric Motility Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Gastric Motility Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Gastric Motility Drugs Market Competitive Situation by Manufacturers in 2023

Table 4. Global Gastric Motility Drugs Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Gastric Motility Drugs Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Gastric Motility Drugs Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Gastric Motility Drugs Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Gastric Motility Drugs Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Gastric Motility Drugs, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Gastric Motility Drugs, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Gastric Motility Drugs, Product Type & Application

Table 12. Global Key Manufacturers of Gastric Motility Drugs, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Gastric Motility Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastric Motility Drugs as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Gastric Motility Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Gastric Motility Drugs Sales by Region (2019-2024) & (K Units)

Table 18. Global Gastric Motility Drugs Sales Market Share by Region (2019-2024)

Table 19. Global Gastric Motility Drugs Sales by Region (2025-2030) & (K Units)

Table 20. Global Gastric Motility Drugs Sales Market Share by Region (2025-2030)

Table 21. Global Gastric Motility Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Gastric Motility Drugs Revenue Market Share by Region (2019-2024)

Table 23. Global Gastric Motility Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Gastric Motility Drugs Revenue Market Share by Region (2025-2030)

Table 25. North America Gastric Motility Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Gastric Motility Drugs Sales by Country (2019-2024) & (K Units)

Table 27. North America Gastric Motility Drugs Sales by Country (2025-2030) & (K Units)

Table 28. North America Gastric Motility Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Gastric Motility Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Gastric Motility Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Gastric Motility Drugs Sales by Country (2019-2024) & (K Units)

Table 32. Europe Gastric Motility Drugs Sales by Country (2025-2030) & (K Units)

Table 33. Europe Gastric Motility Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Gastric Motility Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Gastric Motility Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Gastric Motility Drugs Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Gastric Motility Drugs Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Gastric Motility Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Gastric Motility Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Gastric Motility Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Gastric Motility Drugs Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Gastric Motility Drugs Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Gastric Motility Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Gastric Motility Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Gastric Motility Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Gastric Motility Drugs Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Gastric Motility Drugs Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Gastric Motility Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Gastric Motility Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Gastric Motility Drugs Sales (K Units) by Type (2019-2024)

Table 51. Global Gastric Motility Drugs Sales (K Units) by Type (2025-2030)

Table 52. Global Gastric Motility Drugs Sales Market Share by Type (2019-2024)

Table 53. Global Gastric Motility Drugs Sales Market Share by Type (2025-2030)

Table 54. Global Gastric Motility Drugs Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Gastric Motility Drugs Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Gastric Motility Drugs Revenue Market Share by Type (2019-2024)

Table 57. Global Gastric Motility Drugs Revenue Market Share by Type (2025-2030)

Table 58. Global Gastric Motility Drugs Price (US$/Unit) by Type (2019-2024)

Table 59. Global Gastric Motility Drugs Price (US$/Unit) by Type (2025-2030)

Table 60. Global Gastric Motility Drugs Sales (K Units) by Application (2019-2024)

Table 61. Global Gastric Motility Drugs Sales (K Units) by Application (2025-2030)

Table 62. Global Gastric Motility Drugs Sales Market Share by Application (2019-2024)

Table 63. Global Gastric Motility Drugs Sales Market Share by Application (2025-2030)

Table 64. Global Gastric Motility Drugs Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Gastric Motility Drugs Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Gastric Motility Drugs Revenue Market Share by Application (2019-2024)

Table 67. Global Gastric Motility Drugs Revenue Market Share by Application (2025-2030)

Table 68. Global Gastric Motility Drugs Price (US$/Unit) by Application (2019-2024)

Table 69. Global Gastric Motility Drugs Price (US$/Unit) by Application (2025-2030)

Table 70. Johnson & Johnson Corporation Information

Table 71. Johnson & Johnson Description and Business Overview

Table 72. Johnson & Johnson Gastric Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Johnson & Johnson Gastric Motility Drugs Product

Table 74. Johnson & Johnson Recent Developments/Updates

Table 75. Sumitomo Dainippon Corporation Information

Table 76. Sumitomo Dainippon Description and Business Overview

Table 77. Sumitomo Dainippon Gastric Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Sumitomo Dainippon Gastric Motility Drugs Product

Table 79. Sumitomo Dainippon Recent Developments/Updates

Table 80. Sanofi Corporation Information

Table 81. Sanofi Description and Business Overview

Table 82. Sanofi Gastric Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Sanofi Gastric Motility Drugs Product

Table 84. Sanofi Recent Developments/Updates

Table 85. Pfizer Corporation Information

Table 86. Pfizer Description and Business Overview

Table 87. Pfizer Gastric Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Pfizer Gastric Motility Drugs Product

Table 89. Pfizer Recent Developments/Updates

Table 90. Teva Corporation Information

Table 91. Teva Description and Business Overview

Table 92. Teva Gastric Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Teva Gastric Motility Drugs Product

Table 94. Teva Recent Developments/Updates

Table 95. GrupoFarma Corporation Information

Table 96. GrupoFarma Description and Business Overview

Table 97. GrupoFarma Gastric Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. GrupoFarma Gastric Motility Drugs Product

Table 99. GrupoFarma Recent Developments/Updates

Table 100. Abbott Corporation Information

Table 101. Abbott Description and Business Overview

Table 102. Abbott Gastric Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Abbott Gastric Motility Drugs Product

Table 104. Abbott Recent Developments/Updates

Table 105. Kyowa Kirin Corporation Information

Table 106. Kyowa Kirin Description and Business Overview

Table 107. Kyowa Kirin Gastric Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. Kyowa Kirin Gastric Motility Drugs Product

Table 109. Kyowa Kirin Recent Developments/Updates

Table 110. Sigma-Tau Group Corporation Information

Table 111. Sigma-Tau Group Description and Business Overview

Table 112. Sigma-Tau Group Gastric Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Sigma-Tau Group Gastric Motility Drugs Product

Table 114. Sigma-Tau Group Recent Developments/Updates

Table 115. Wilmington Corporation Information

Table 116. Wilmington Description and Business Overview

Table 117. Wilmington Gastric Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. Wilmington Gastric Motility Drugs Product

Table 119. Wilmington Recent Developments/Updates

Table 120. Chengdu Kanghong Pharmaceutical Group Co.,Ltd Corporation Information

Table 121. Chengdu Kanghong Pharmaceutical Group Co.,Ltd Description and Business Overview

Table 122. Chengdu Kanghong Pharmaceutical Group Co.,Ltd Gastric Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 123. Chengdu Kanghong Pharmaceutical Group Co.,Ltd Gastric Motility Drugs Product

Table 124. Chengdu Kanghong Pharmaceutical Group Co.,Ltd Recent Developments/Updates

Table 125. Lunan Pharmaceutical Group Corporation Corporation Information

Table 126. Lunan Pharmaceutical Group Corporation Description and Business Overview

Table 127. Lunan Pharmaceutical Group Corporation Gastric Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 128. Lunan Pharmaceutical Group Corporation Gastric Motility Drugs Product

Table 129. Lunan Pharmaceutical Group Corporation Recent Developments/Updates

Table 130. Hansoh Pharmaceutical Group Company Limited Corporation Information

Table 131. Hansoh Pharmaceutical Group Company Limited Description and Business Overview

Table 132. Hansoh Pharmaceutical Group Company Limited Gastric Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 133. Hansoh Pharmaceutical Group Company Limited Gastric Motility Drugs Product

Table 134. Hansoh Pharmaceutical Group Company Limited Recent Developments/Updates

Table 135. Shanghai Sine Pharmaceutical Laboratories Co., Ltd Corporation Information

Table 136. Shanghai Sine Pharmaceutical Laboratories Co., Ltd Description and Business Overview

Table 137. Shanghai Sine Pharmaceutical Laboratories Co., Ltd Gastric Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 138. Shanghai Sine Pharmaceutical Laboratories Co., Ltd Gastric Motility Drugs Product

Table 139. Shanghai Sine Pharmaceutical Laboratories Co., Ltd Recent Developments/Updates

Table 140. Disha Pharmaceutical Group Co., Ltd Corporation Information

Table 141. Disha Pharmaceutical Group Co., Ltd Description and Business Overview

Table 142. Disha Pharmaceutical Group Co., Ltd Gastric Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 143. Disha Pharmaceutical Group Co., Ltd Gastric Motility Drugs Product

Table 144. Disha Pharmaceutical Group Co., Ltd Recent Developments/Updates

Table 145. Xian Janssen Pharmaceutical Ltd Corporation Information

Table 146. Xian Janssen Pharmaceutical Ltd Description and Business Overview

Table 147. Xian Janssen Pharmaceutical Ltd Gastric Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 148. Xian Janssen Pharmaceutical Ltd Gastric Motility Drugs Product

Table 149. Xian Janssen Pharmaceutical Ltd Recent Developments/Updates

Table 150. Key Raw Materials Lists

Table 151. Raw Materials Key Suppliers Lists

Table 152. Gastric Motility Drugs Distributors List

Table 153. Gastric Motility Drugs Customers List

Table 154. Gastric Motility Drugs Market Trends

Table 155. Gastric Motility Drugs Market Drivers

Table 156. Gastric Motility Drugs Market Challenges

Table 157. Gastric Motility Drugs Market Restraints

Table 158. Research Programs/Design for This Report

Table 159. Key Data Information from Secondary Sources

Table 160. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Gastric Motility Drugs

Figure 2. Global Gastric Motility Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Gastric Motility Drugs Market Share by Type in 2023 & 2030

Figure 4. Monotherapy Product Picture

Figure 5. Poly Pill Product Picture

Figure 6. Global Gastric Motility Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Gastric Motility Drugs Market Share by Application in 2023 & 2030

Figure 8. Chronic Gastritis

Figure 9. Reflux Esophagitis

Figure 10. Functional Dyspepsia

Figure 11. Others

Figure 12. Global Gastric Motility Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Gastric Motility Drugs Market Size (2019-2030) & (US$ Million)

Figure 14. Global Gastric Motility Drugs Sales (2019-2030) & (K Units)

Figure 15. Global Gastric Motility Drugs Average Price (US$/Unit) & (2019-2030)

Figure 16. Gastric Motility Drugs Report Years Considered

Figure 17. Gastric Motility Drugs Sales Share by Manufacturers in 2023

Figure 18. Global Gastric Motility Drugs Revenue Share by Manufacturers in 2023

Figure 19. The Global 5 and 10 Largest Gastric Motility Drugs Players: Market Share by Revenue in 2023

Figure 20. Gastric Motility Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 21. Global Gastric Motility Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 22. North America Gastric Motility Drugs Sales Market Share by Country (2019-2030)

Figure 23. North America Gastric Motility Drugs Revenue Market Share by Country (2019-2030)

Figure 24. United States Gastric Motility Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Canada Gastric Motility Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Europe Gastric Motility Drugs Sales Market Share by Country (2019-2030)

Figure 27. Europe Gastric Motility Drugs Revenue Market Share by Country (2019-2030)

Figure 28. Germany Gastric Motility Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. France Gastric Motility Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. U.K. Gastric Motility Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Italy Gastric Motility Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Russia Gastric Motility Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Asia Pacific Gastric Motility Drugs Sales Market Share by Region (2019-2030)

Figure 34. Asia Pacific Gastric Motility Drugs Revenue Market Share by Region (2019-2030)

Figure 35. China Gastric Motility Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Japan Gastric Motility Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. South Korea Gastric Motility Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. India Gastric Motility Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Australia Gastric Motility Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. China Taiwan Gastric Motility Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Southeast Asia Gastric Motility Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Latin America Gastric Motility Drugs Sales Market Share by Country (2019-2030)

Figure 43. Latin America Gastric Motility Drugs Revenue Market Share by Country (2019-2030)

Figure 44. Mexico Gastric Motility Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Brazil Gastric Motility Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Argentina Gastric Motility Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Middle East & Africa Gastric Motility Drugs Sales Market Share by Country (2019-2030)

Figure 48. Middle East & Africa Gastric Motility Drugs Revenue Market Share by Country (2019-2030)

Figure 49. Turkey Gastric Motility Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Saudi Arabia Gastric Motility Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. UAE Gastric Motility Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Global Sales Market Share of Gastric Motility Drugs by Type (2019-2030)

Figure 53. Global Revenue Market Share of Gastric Motility Drugs by Type (2019-2030)

Figure 54. Global Gastric Motility Drugs Price (US$/Unit) by Type (2019-2030)

Figure 55. Global Sales Market Share of Gastric Motility Drugs by Application (2019-2030)

Figure 56. Global Revenue Market Share of Gastric Motility Drugs by Application (2019-2030)

Figure 57. Global Gastric Motility Drugs Price (US$/Unit) by Application (2019-2030)

Figure 58. Gastric Motility Drugs Value Chain

Figure 59. Gastric Motility Drugs Production Process

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Distributors Profiles

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-0F18702

Tue Oct 22 00:00:00 UTC 2024

Add to Cart

Severe Hypertriglyceridemia (SHTG) Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-3Y14261

Mon Oct 21 00:00:00 UTC 2024

Add to Cart

Birch Allergy Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-29C13700

Mon Oct 21 00:00:00 UTC 2024

Add to Cart

Lithotripsy Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-15D7478

Tue Oct 15 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Gastric Motility Drugs Market Research Report 2024

Published Date: July 2024

Report Code: QYRE-Auto-31V12802

Global Gastric Motility Drugs Market Research Report 2024

FEATURED COMPANIES

Gastric Motility Drugs Market Size

Gastric Motility Drugs Market

Report Scope

Scope of Gastric Motility Drugs Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Gastric Motility Drugs Market report?

What are the Application segmentation covered in the Gastric Motility Drugs Market report?

What are the Type segmentation covered in the Gastric Motility Drugs Market report?

FEATURED COMPANIES

RELATED REPORTS